From pioneering treatments to transformative patient care, the Preston Robert Tisch Brain Tumor Center is at the forefront of global brain tumor research. Discover recent press features and stories showcasing our work and the people behind it.
Seeds of Hope
Dr. Darell Bigner journeys from the farm to the heights of neuro-oncology and back again
Vice President Biden meets Patient No. 1
VP Biden toured Duke labs to learn about the polio trial for the Cancer Moonshot Initiative. There he met Patient No. 1, Stephanie Lipscomb
From survival mode to change agent
A brain cancer survivor and Iowa business owner now leads executive philanthropy to raise millions of dollars for Duke’s brain tumor research
Terminally ill 80-year-old cancer patient granted wish of a lifetime to see Duke basketball game
The Florida man has always dreamed of attending a Duke Men's Basketball game and he was finally able to accomplish that.
Good Grief
Philanthropist Rebecca Feinglos partners with Duke Health to create a first-of-its-kind program that offers support for patients, families and providers facing life's hardest moments.
Michael Strahan's daughter, Isabella, shares she is cancer-free
Michael Strahan's 19-year-old daughter Isabella is battling a malignant brain tumor known as medulloblastoma.
Durham woman donates $250K to develop grief support program at Duke brain tumor center
After losing both of her parents, Rebecca Feinglos is donating a quarter of a million dollars to Duke University to help others overcome their own grief.
Christina Cone named associate deputy director of Preston Robert Tisch Brain Tumor Center at Duke Health
Christina Cone was named associate deputy director of the Preston Robert Tisch Brain Tumor Center.
International neuro‑oncology leader to join WEHI
Internationally renowned neuro‑oncologist Professor David Ashley will join WEHI as a laboratory head, advancing the ambitious research agenda of The Brain Cancer Centre.
What is glioblastoma? Duke doctor explains the brain cancer after death of "Today" host's husband
After the death of her husband, "Today" show host Sheinelle Jones is raising awareness about glioblastoma, an aggressive form of brain cancer.
Novel Drug Improves Survival in Advanced Brain Cancer
The novel drug BMX-001 showed improved survival in certain patients with high-grade glioma and reduced cognitive decline caused by radiation therapy.
Drug Born at Duke Improves Survival in People with Advanced Brain Cancer
Ines Batinic-Haberle, PhD, professor emeritus of radiation oncology at Duke University School of Medicine, created hundreds of compounds before she hit upon the right one.
Advancements in metastatic cancer treatments offer new hope to patients
"There's a lot of reasons to be optimistic even in the face of a terminal diagnosis," said Kohl.
How Medication Shortages Affect Patients
For people with brain cancer, the combination of amphetamine and dextroamphetamine and methylphenidate (Concerta) are used to treat side effects of chemotherapy such as fatigue, lack of focus, and brain fog, says Mallika Patel, PharmD, a clinical pharmacist specializing in neuro-oncology at the Preston Robert Tisch Brain Tumor Center at Duke University Medical Center in Durham, NC.
Isabella Strahan shares she is cancer-free: 'Everything is clear'
In a new update on Thursday from a video on her YouTube channel, the 19-year-old daughter of "Good Morning America" co-anchor Michael Strahan shared that she is officially cancer-free.
Groundbreaking New Cancer Medication Stops Growth Of Brain Tumors
With nearly 25,000 people expected to be diagnosed with a malignant brain and spinal cord tumor, it’s clear that medication like this has the power to change so many lives.
Herpes Virus Can Cause The Brain Cancer That Took Senators Ted Kennedy and John McCain, New Findings From Respected Medical Researchers
Dr. Allan Friedman performed that operation, noting it was “successful” and that the politician was awake during the resection, and should therefore experience no permanent neurological effects from the surgery.
Episode 116: Understanding Vorasidenib's Therapeutic Benefit on Neurocognition, Seizure Control in Diffuse Gliomas
Episode 116, "Understanding Vorasidenib's Therapeutic Benefit on Neurocognition, Seizure Control in Diffuse Gliomas" features a conversation with Katherine Peters, PhD, a neurologist and neurooncologist at the Preston Robert Tisch Brain Tumor Center at Duke University provided context on a new analysis from the phase 3 INDIGO trial, a study assessing vorasidenib in patients with mutant isocitrate dehydrogenase (mIDH) 1/2 diffuse gliomas.
Mia Love on faith helping with her cancer diagnosis
CNN's Jake Tapper reports
Ojemda Preserves Quality of Life, Limits Cognitive Effects in Low-Grade Glioma
Ojemda is the first FDA-approved treatment for patients with pediatric low-grade glioma who have BRAF fusions, according to Dr. Daniel Landi, a pediatric neuro-oncologist at Duke Cancer Institute in Durham, North Carolina.